Eswatini begins administering a groundbreaking HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden. Lenacapavir, which is taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, making it functionally akin to a powerful vaccine. Eswatini -- a tiny kingdom of 1.2 million -- has about 220,000 people living with the virus. Interested in licensing this video ? Get in touch 👉 http://u.afp.com/